FOLH1 and prostate cancer: Background: Positron emission tomography-computed tomography with prostate-specific membrane antigen (PET-CT PSMA) has revolutionized the preoperative staging of prostate cancer, particularly for assessing seminal vesicle and lymph node invasion.